Effects of extended-release memantine (28 mg, once daily) on language and communication abilities in a randomized trial of patients with moderate-to-severe Alzheimer's disease

Category Primary study
JournalAlzheimer's and Dementia
Year 2012
This article has no abstract
Epistemonikos ID: a50a75a524fd2e05c24729a410272bb51d8dd996
First added on: Feb 05, 2025